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EDITORIAL

Advances in Chronic Kidney Disease as
Syntopicon

A

dvances in Chronic Kidney Disease began its life under
the aegis of Allen R. Nissenson as the ﬁrst Editor-inChief of Advances in Renal Replacement Therapy.1 Dr. Nissenson’s expressed desire was for A-R-R-T to become the
“art” of renal replacement therapy. He explicitly stated
this aspiration, echoing the enthusiastic prose of Dr. Seuss,
in his inaugural editorial in April 1994, “The ARRT of Uremia Therapy.”1 Instrumental to the journal’s conception
was much the effort of Garabed Eknoyan—a long-time
advisor-contributor to the National Kidney Foundation
in so many ways. He and others realized that the prominent journals in Nephrology had “orphaned” renal
replacement therapy “for quite a while,” and that change
was required.2 Topics regarding hemodialysis were its
forte with peritoneal dialysis highlighted as well. James
Winchester who had participated in ARRT’s ﬁrst Editorin-Chief selection committee became the A-R-R-T’s second
Editor-in-Chief in January 1999. ARRT continued to publish high-quality manuscripts principally involving kidney replacement therapy. In January 2004, Dr.
Winchester’s successor, Wendy Brown, became the third
Editor-in-Chief. She reincarnated the journal as Advances
in Chronic Kidney Disease (A-C-K-D), which immediately
and presagingly positioned it as a vehicle for timely, thematic reporting of issues, both old and new, within the
burgeoning world of CKD. The title word, “Advances,”
was chosen to reﬂect the journal’s evolution and progression to a rapidly enlarging nephrological platform.
During my 11-year tenure as A-C-K-D’s fourth Editor-inChief, the journal has become a bimonthly meme of the clinical nephrologist’s world. The editorial staff tasked itself
with the lofty ideal of becoming the kidney-centric manifestation of the University of Chicago philosopher Mortimer
Adler’s compilation, A Syntopicon: An Index to the Great
Ideas. Published as volumes 2 and 3 of Encyclopædia Britannica’s collection “Great Books of the Western World,” Adler
patiently and unerringly compiled the fundamental precepts of 102 great minds from Homer to Freud.3,*
A-C-K-D has presented a host of timely topics, Great Kidney Ideas. The editorial staff of A-C-K-D has responded 66
times to the challenge of presenting contemporary and
speciﬁc problems in CKD in a reader-friendly format after

thorough and comprehensive peer review. The themes
published encompassed multiple, speciﬁc areas of CKD,
including its intersections with acute kidney injury,
infections, glomerular ﬁltration rate, electrolyte and
acid-base disorders, glomerular disorders, intensive care
nephrology, transplantation, hypertension, exercise, endstage renal disease, toxins, viral nephropathies, and
others. The Guest Editors judiciously canvassed their
respective landscapes of expertise to cajole their respective
authors into writing for A-C-K-D. In the end, the authors
penned a ﬁnely crafted series of papers that inﬂuenced
theory and practice . and with great artwork.
In principle, this journal has become, to some extent, a
renal syntopicon, whereby a few watched for the many.
Namely, our expert, ever-vigilant, and multifaceted editorial board continually surveilled the renal landscape for
nascent concepts that could become canon, or, at least,
controversial.3 With our Guest Editors, the editorial staff
stiﬂed any of my own implicit biases, and offered highquality, balanced work to our readers.
It has been an enormous privilege to guide, mentor, and
learn from so many. The list is long and includes the ultraprofessional staff of the medical publishing house, Elsevier, with special gratitude to Elsevier personnel, Kate
Williamson, Sarah Pratta, and Livia Berardi as well as
Kendra Clayton, Jason Woodson, Lisa Johnson, and
Catherine Desko; the leadership of the National Kidney
Foundation, with sincerest thanks to Jessica Joseph and

*
Compiled by Mortimer Adler, an American philosopher, under the
guidance of Robert Hutchins, president of the University of Chicago, the
two volumes represent a compendium of the 102 Great Ideas of the
Western canon. The term “syntopicon” was coined speciﬁcally for this
undertaking, meaning “a collection of topics.” The volumes cataloged
what Adler and his team deemed to be the fundamental ideas contained
in the works of the Great Books of the Western World, which stretched
chronologically from Homer to Freud. The Syntopicon lists, under each
idea, where every occurrence of the concept can be located in the
collection’s famous works.
Ó 2019 by the National Kidney Foundation, Inc. All rights reserved.
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Kerry Willis; A-C-K-D’s ausgezeichnet Associate Editors,
past and current; and nonpareil Editorial Board, all of
whom sacriﬁced personal time to properly prepare
each issue. External assistance was always “at-the-ready.”
Stephanie Stebens, MLIS, facilitated manuscript
preparation, and helped us achieve our deadlines
more times than I can recall. Medical writer, Sarah
Whitehouse, MAW, proofread many papers with
potential, and transformed them into publication-worthy
manuscripts. Author, English teacher, and advisor James
Kelly read nearly all my occasionally “semi-demagogic”
editorials, and improved them with sage Mark
Twain-like advice.
No amount of appreciation expresses the debt that
this journal and I owe to our “Managing Editor,”
Dr. Nandita Mani, PhD, who indefatigably and
graciously corrected this journal’s course innumerable
times. Her unparalleled ability to “dead reckon”
permitted the recalculation of our course as required,
and led us to this portion of A-C-K-D’s journey.
Without her untiring guidance, we would not have
landed where we are now. I am conﬁdent that our
current position, farther than we were but not yet
where we must go, is a good one. I am equally certain
as the journal passes into the highly capable hands of
Dr. Charuhas Thakar, MD, and his Editorial Board
that the panoptic syntopicon that Advances in Chronic
Kidney Disease has become will continue its forward
progress on multiple fronts.4
For now, Guest Editor, Sagar U. Nigwekar, MD, MMSc,
elucidates in part the vexing disorder, calciﬁc uremic
arteriolopathy, or calciphylaxis to us oldsters who thought
that this cutaneous catastrophe only afﬂicted individuals
with end-stage renal disease. However, this terrifying
and horribly painful skin disease has monstrously made
its appearance in the non-CKD world, that is, calciﬁc
uremic arteriolopathy (CUA) has been repeatedly
diagnosed in patients with normal glomerular ﬁltration
rates. Unfortunately, we do not yet know enough to
prevent CUA, but more than a glimmer of hope is
presented in this issue. So, readers, do what you do.
Keep reading as this journal continues its dedication to

Awesome, Comprehensive Knowledge Dissemination.
I will, and thank you.

Jerry Yee
Editor-in-Chief
Henry Ford Hospital
Detroit, MI
Professor of Clinical Medicine
Wayne State University
Detroit, MI
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